Extract
There is increasing research on oscillometry, and increased interest and feasibility in its clinical application. Respiratory oscillometry measures the mechanical properties of the respiratory system (upper and intrathoracic airways, lung tissue and chest wall) during quiet tidal breathing, by the application of small pressure or flow oscillations (input or forcing signal) most commonly at the mouth.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. King reports grants from ATS and ERS, during the conduct of the study; other from Restech, grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Menarini, MundiPharma, Cyclomedica, grants from NH&MRC, Philanthropic Societies, Sydney University, outside the submitted work.
Conflict of interest: Dr. Bates reports personal fees from Oscillavent, LLC, outside the submitted work; In addition, Dr. Bates has a patent Patent application US 20160007882 A1 pending to none, and a patent PCT Application WO2015127377 A1 pending to none.
Conflict of interest: Dr. Berger has nothing to disclose.
Conflict of interest: PMAC has advised Philips Respironics about the clinical application of FOT and spoken on this topic at meetings supported by this company.
Conflict of interest: Dr. Melo reports In addition, Dr. Melo has a patent 28727 issued.
Conflict of interest: Dr. Dellaca’ reports In addition, Dr. Dellaca’ has a patent on the detection of EFL by FOT with royalties paid to Philips Respironics and Restech srl, a patent on monitoring lung volume recruitment by FOT with royalties paid to Vyaire, and a patent on early detection of exacerbations by home monitoring of FOT with royalties paid to Restech and is co-founder and shareholder of Restech srl, a spin-off company of the Politecnico di Milano University producing medical devices for lung function testing based on FOT.
Conflict of interest: Dr. Farre reports other from Resmed, other from ANTADIR, outside the submitted work.
Conflict of interest: Dr. Hall reports grants from American Thoracic Society, grants from European Respiratory Society, during the conduct of the study.
Conflict of interest: Dr. IOAN has nothing to disclose.
Conflict of interest: Dr. Irvin reports other from Methapharm, personal fees and non-financial support from Medical Graphics Corp, grants from NIH, grants from Americal Lung Association, outside the submitted work.
Conflict of interest: Dr. Kaczka reports grants from U.S. Department of Defense, grants from National Institutes of Health, grants from National Institutes of Health, grants from National Institutes of Health, other from OscillaVent, Inc., during the conduct of the study; grants from ZOLL Medical Corporation, non-financial support from Monitor Mask, Inc., outside the submitted work; In addition, Dr. Kaczka has a patent Systems and methods for multi-frequency oscillator ventilation pending to OscillaVent, Inc., a patent Treatment of respiratory condition using targeted delivery pending, a patent System and Method For Setting Positive End Expiratory Pressure During Mechanical Ventilation Based on Dynamic Lung Function pending, a patent Enhanced Ventilation Waveform Device issued, and a patent Servo-controlled pneumatic pressure oscillator for respiratory impedance measurements and high-frequency ventilation pending.
Conflict of interest: Dr. Kaminsky reports personal fees from MGC Diagnostics, Inc., outside the submitted work.
Conflict of interest: Dr. Kurosawa reports grants and personal fees from Chest M.I. Inc., during the conduct of the study; personal fees from Nippon Boheringer Ingelheim Co. Ltd., outside the submitted work; In addition, Dr. Kurosawa has a patent US2012101400 with royalties paid to Tohoku University.
Conflict of interest: Dr. Lombardi reports personal fees from Angelini, personal fees from Boehringer, grants and personal fees from Chiesi, personal fees from GSK, grants and personal fees from Lusofarmaco, grants and personal fees from Novartis, personal fees from Omron, grants and non-financial support from ResTech, personal fees and non-financial support from Vertex, personal fees from Vifor, outside the submitted work.
Conflict of interest: Dr. Maksym reports financial support from Thorasys, Thoracic Medical Systems Inc, prior to the submitted work and non-financial support from Thorasys during the submitted work; In addition, Dr. Maksym has a patent Respiratory Device (design patent) issued to Thorasys, a patent Respiratory Device filter issued to Thorasys, a patent Piezoelectric beam bending actuated Device for measuring respiratory system impedance issued to Thorasys, and a patent Method of assessment of airway variability in airway hyperresponsiveness issued to Thorasys
Conflict of interest: Dr. Marchal has nothing to disclose.
Conflict of interest: Dr. Oppenheimer has nothing to disclose.
Conflict of interest: Dr. Simpson has nothing to disclose.
Conflict of interest: Dr. Thamrin has a patent WO 2006130922 A1 issued which is broadly relevant to the work. In addition, Dr. Thamrin has intellectual property arrangements with Thorasys Medical Systems and Restech srl relating to research collaborations, but does not have any financial relationships with either company.
Conflict of interest: Dr. van den Berge reports grants paid to the University from Astra Zeneca, TEVA, GSK, Chiesi, outside the submitted work.
Conflict of interest: Dr. Oostveen has nothing to disclose.
- Received April 14, 2019.
- Accepted October 15, 2019.
- Copyright ©ERS 2019